Background Localised prostate cancer is commonly treated with external beam radiotherapy
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …

Background Localised prostate cancer is commonly treated with external-beam
radiotherapy. Moderate hypofractionation has been shown to be non-inferior to conventional …

Purpose/Objective (s) External beam radiotherapy (EBRT) is a curative treatment for
Localized Prostate Cancer (LPCa). Large randomized controlled trials (RCTs) have shown …

Background Stereotactic body radiation therapy is an emerging treatment for prostate cancer
(PC), with potential biological and oncologic advantages. A well-established radiation …

Purpose To evaluate the tolerability of escalating doses of stereotactic body radiation
therapy in the treatment of localized prostate cancer. Patients and Methods Eligible patients …

Purpose Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …

Purpose Hypofractionated, stereotactic body radiotherapy (SBRT) is an emerging treatment
approach for prostate cancer. We present the outcomes for low-risk prostate cancer patients …

Purpose Stereotactic body radiation therapy (SBRT) is a technically demanding prostate
cancer treatment that may be less expensive than intensity-modulated radiation therapy …

Background We report the outcome of a phase I/II clinical trial of stereotactic body radiation
therapy (SBRT) for low (LR) and select intermediate risk (IR) prostate cancer (PCa) patients …

Importance Stereotactic body radiotherapy harnesses improvements in technology to allow
the completion of a course of external beam radiotherapy treatment for prostate cancer in the …